Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Alcohol Drinking 3Wounds and Injuries 1Tuberculosis 1Smoking Cessation 1Risk-Taking 1Prostatic Neoplasms 1Mouth Neoplasms 1Lymphoma, Follicular 1Liver Cirrhosis 1Infections 1Fanconi Anemia 1Diabetes Mellitus, Type 2 1Depression 1Dementia 1Cardiovascular Diseases 1Binge-Eating Disorder 1Binge Drinking 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 4gamma-Globulins 3Ciprofloxacin 3Immunoglobulins, Intravenous 2Amoxicillin-Potassium Clavulanate Combination 2talquetamab 1plerixafor 1idecabtagene vicleucel 1anifrolumab 1Wearable Electronic Devices 1Vital Signs 1Procalcitonin 1Plastic Surgery Procedures 1Immunoglobulins 1Fish Oils 1Ethanol 1Enteral Nutrition 1Dietary Supplements 1Cystectomy 1Control Groups 1Clavulanic Acid 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Infections × Ethanol × Clear all
NCT06338215 2024-12-12

UNATI

Clinica Universidad de Navarra, Universidad de Navarra

Phase NA Recruiting
10,000 enrolled

Cardiovascular Diseases, Dementia, Depression, Diabetes Mellitus, Type 2, Infections, Liver Cirrhosis, Tuberculosis, Wounds and Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡